These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 15739096)
1. Endothelial functions in Behçet's disease. Kayikçioğlu M; Aksu K; Hasdemir C; Keser G; Turgan N; Kültürsay H; Doganavsargil E Rheumatol Int; 2006 Feb; 26(4):304-8. PubMed ID: 15739096 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial function and plasma homocysteine levels in Behcet's disease. Ozdemir R; Barutcu I; Sezgin AT; Acikgoz N; Ermis N; Esen AM; Topal E; Bariskaner E; Ozerol I Am J Cardiol; 2004 Aug; 94(4):522-5. PubMed ID: 15325946 [TBL] [Abstract][Full Text] [Related]
3. Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement. Oflaz H; Mercanoglu F; Karaman O; Kamali S; Erer B; Genchellac H; Pamukcu B; Umman S; Inanc M; Gul A Int J Clin Pract; 2005 Jul; 59(7):777-81. PubMed ID: 15963203 [TBL] [Abstract][Full Text] [Related]
4. Effect of nebivolol on endothelial dysfunction in patients with Behçet's disease; a prospective single-arm controlled study. Akkaya H; Sahin O; Borlu M; Oğuzhan A; Karakaş MS Anadolu Kardiyol Derg; 2013 Mar; 13(2):115-20. PubMed ID: 23228972 [TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin D deficiency and replacement on endothelial functions in Behçet's disease. Can M; Gunes M; Haliloglu OA; Haklar G; Inanç N; Yavuz DG; Direskeneli H Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S57-61. PubMed ID: 23020973 [TBL] [Abstract][Full Text] [Related]
6. Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behçet disease. Ozuguz P; Karabulut AA; Tulmac M; Kisa U; Kocak M; Gunduz O Angiology; 2014 Nov; 65(10):937-43. PubMed ID: 24277913 [TBL] [Abstract][Full Text] [Related]
7. Endothelial functions are more severely impaired during active disease period in patients with Behcet's disease. Caliskan M; Yilmaz S; Yildirim E; Gullu H; Erdogan D; Ciftci O; Kaynar G; Yucel E; Muderrisoglu H Clin Rheumatol; 2007 Jul; 26(7):1074-8. PubMed ID: 17089218 [TBL] [Abstract][Full Text] [Related]
8. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio. Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular prognostic value of vascular involvement in Behcet's disease. Caliskan M; Gullu H; Yilmaz S; Ciftci O; Erdogan D; Dursun R; Yucel E; Muderrisoglu H Int J Cardiol; 2008 Apr; 125(3):428-30. PubMed ID: 17408778 [TBL] [Abstract][Full Text] [Related]
10. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734 [TBL] [Abstract][Full Text] [Related]
12. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688 [TBL] [Abstract][Full Text] [Related]
13. Serum homocysteine level is higher in Behçet's disease with vascular involvement. Ateş A; Aydintuğ O; Olmez U; Düzgün N; Duman M Rheumatol Int; 2005 Jan; 25(1):42-4. PubMed ID: 14586553 [TBL] [Abstract][Full Text] [Related]
14. Coagulation parameters and plasma total homocysteine levels in Behcet's disease. Lee YJ; Kang SW; Yang JI; Choi YM; Sheen D; Lee EB; Choi SW; Song YW Thromb Res; 2002 Apr; 106(1):19-24. PubMed ID: 12165284 [TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis. Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001 [TBL] [Abstract][Full Text] [Related]
16. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study. Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874 [TBL] [Abstract][Full Text] [Related]
17. Relationship between serum homocysteine levels and structural-functional carotid arterial abnormalities in inactive Behçet's disease. Ozdemir R; Yagmur J; Acikgoz N; Cansel M; Karincaoglu Y; Ermis N; Pekdemir H; Arslan AK Kardiol Pol; 2018; 76(2):413-417. PubMed ID: 29192953 [TBL] [Abstract][Full Text] [Related]
18. Homocysteine: an activity marker in Behçet's disease? Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219 [TBL] [Abstract][Full Text] [Related]
19. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease. Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919 [TBL] [Abstract][Full Text] [Related]
20. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease. Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]